semaglutide – Talk Bio

Compounding pharmacies dealt a blow in fight over end of semaglutide shortage

16 hours ago talkbio0Tagged Compound, enforcement, Pharmacy facility, semaglutide, shortage, United States Food and Drug Administration, Wegovy

United States Food and Drug Administration, semaglutide, Compound, enforcement, Pharmacy facility, shortage, Wegovy

Facing added pressure from Eli Lilly, Novo Nordisk submits for FDA approval of oral GLP-1 obesity drug

4 days ago talkbio0Tagged Approved, competition, eli lilly, Glucagon-Like Peptide 1, Market, Nordisk, Novo, Obesity, Oral cavity, Pressure- physical agent, semaglutide, United States Food and Drug Administration

Nordisk, Obesity, Approved, Oral cavity, Glucagon-Like Peptide 1, Market, Pressure- physical agent, eli lilly, competition, Novo, semaglutide, United States Food and Drug Administration, United States Food and Drug Administration

Novo’s Studies of GLP-1s for Addiction Limited to Ongoing Phase II

2 months ago talkbio0Tagged addiction, Clinical Trials, Glucagon-Like Peptide 1, Nordisk, semaglutide

GLP-1, addiction treatment, semaglutide, clinical trials, Novo Nordisk

Novo Nordisk Slashes Wegovy Price for Cash-Paying Patients

2 months ago talkbio0Tagged cash-paying, direct-to-patient, Nordisk, NovoCare, Obesity, Pharmaceutical Services, Prices, semaglutide, Wegovy

Wegovy, price cut, Novo Nordisk, NovoCare Pharmacy, obesity treatment, semaglutide, direct-to-patient, cash-paying patients

Hims eyes growth in its weight loss business, despite end of semaglutide shortage

2 months ago talkbio0Tagged Growth, Hims, semaglutide, United States Food and Drug Administration, weight loss business

semaglutide, weight loss business, United States Food and Drug Administration, Growth, Hims

Compounders Sue FDA Over Removal of Semaglutide from Drug Shortage List

2 months ago talkbio0Tagged Compounders, Drug Shortage, facilities, Mental association, semaglutide, United States Food and Drug Administration, Wegovy

Semaglutide, FDA, drug shortage, compounders, lawsuit, Ozempic, Wegovy, Outsourcing Facilities Association

Semaglutide Shows Promise in Reducing Alcohol Consumption, Small Study Reveals

2 months ago talkbio0Tagged addiction, Alcohol Use Disorder, Craving for alcohol, Glucagon-Like Peptide 1, semaglutide, Wegovy, Weight Loss Medication

semaglutide, Ozempic, Wegovy, alcohol use disorder, GLP-1 drugs, alcohol cravings, weight loss medication, addiction treatment

FDA Approves Ozempic for Reducing Kidney Disease Risks in Adults with Type 2 Diabetes and Chronic Kidney Disease

3 months ago talkbio0Tagged Agonist, Approved, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes, GLP-1 receptor, Kidney Diseases, Ozempic, Risk, semaglutide, United States Food and Drug Administration

Ozempic, FDA Approval, Type 2 Diabetes, Chronic Kidney Disease (CKD), Kidney Disease Risks, Cardiovascular Disease Risks, Semaglutide, GLP-1 Receptor Agonist